S&P 500   2,749.98 (+3.41%)
DOW   23,433.57 (+3.44%)
QQQ   200.57 (+2.12%)
AAPL   266.07 (+2.56%)
FB   174.28 (+3.23%)
MSFT   165.13 (+1.00%)
GOOGL   1,207.00 (+2.07%)
AMZN   2,043.00 (+1.56%)
CGC   14.83 (+2.28%)
NVDA   266.95 (+3.06%)
BABA   195.98 (-1.02%)
MU   48.29 (+3.76%)
GE   7.30 (+3.84%)
TSLA   548.84 (+0.62%)
AMD   48.79 (+2.59%)
T   29.89 (-0.63%)
ACB   0.85 (+6.23%)
F   5.03 (+6.79%)
NFLX   371.12 (-0.31%)
BAC   23.45 (+5.92%)
GILD   74.99 (+0.43%)
DIS   101.07 (-0.17%)
PRI   97.51 (+10.73%)
S&P 500   2,749.98 (+3.41%)
DOW   23,433.57 (+3.44%)
QQQ   200.57 (+2.12%)
AAPL   266.07 (+2.56%)
FB   174.28 (+3.23%)
MSFT   165.13 (+1.00%)
GOOGL   1,207.00 (+2.07%)
AMZN   2,043.00 (+1.56%)
CGC   14.83 (+2.28%)
NVDA   266.95 (+3.06%)
BABA   195.98 (-1.02%)
MU   48.29 (+3.76%)
GE   7.30 (+3.84%)
TSLA   548.84 (+0.62%)
AMD   48.79 (+2.59%)
T   29.89 (-0.63%)
ACB   0.85 (+6.23%)
F   5.03 (+6.79%)
NFLX   371.12 (-0.31%)
BAC   23.45 (+5.92%)
GILD   74.99 (+0.43%)
DIS   101.07 (-0.17%)
PRI   97.51 (+10.73%)
S&P 500   2,749.98 (+3.41%)
DOW   23,433.57 (+3.44%)
QQQ   200.57 (+2.12%)
AAPL   266.07 (+2.56%)
FB   174.28 (+3.23%)
MSFT   165.13 (+1.00%)
GOOGL   1,207.00 (+2.07%)
AMZN   2,043.00 (+1.56%)
CGC   14.83 (+2.28%)
NVDA   266.95 (+3.06%)
BABA   195.98 (-1.02%)
MU   48.29 (+3.76%)
GE   7.30 (+3.84%)
TSLA   548.84 (+0.62%)
AMD   48.79 (+2.59%)
T   29.89 (-0.63%)
ACB   0.85 (+6.23%)
F   5.03 (+6.79%)
NFLX   371.12 (-0.31%)
BAC   23.45 (+5.92%)
GILD   74.99 (+0.43%)
DIS   101.07 (-0.17%)
PRI   97.51 (+10.73%)
S&P 500   2,749.98 (+3.41%)
DOW   23,433.57 (+3.44%)
QQQ   200.57 (+2.12%)
AAPL   266.07 (+2.56%)
FB   174.28 (+3.23%)
MSFT   165.13 (+1.00%)
GOOGL   1,207.00 (+2.07%)
AMZN   2,043.00 (+1.56%)
CGC   14.83 (+2.28%)
NVDA   266.95 (+3.06%)
BABA   195.98 (-1.02%)
MU   48.29 (+3.76%)
GE   7.30 (+3.84%)
TSLA   548.84 (+0.62%)
AMD   48.79 (+2.59%)
T   29.89 (-0.63%)
ACB   0.85 (+6.23%)
F   5.03 (+6.79%)
NFLX   371.12 (-0.31%)
BAC   23.45 (+5.92%)
GILD   74.99 (+0.43%)
DIS   101.07 (-0.17%)
PRI   97.51 (+10.73%)
Log in

NASDAQ:CLGNCOLLPLANT HOLDI/S Stock Price, Forecast & News

$9.74
+0.69 (+7.62 %)
(As of 04/8/2020 04:00 PM ET)
Add
Compare
Today's Range
$9.37
Now: $9.74
$9.74
50-Day Range
$8.12
MA: $10.34
$13.86
52-Week Range
$3.35
Now: $9.74
$14.55
Volume4,300 shs
Average Volume33,395 shs
Market Capitalization$37.16 million
P/E RatioN/A
Dividend YieldN/A
Beta1.09
CollPlant Holdings Ltd., a regenerative medicine company, focuses on developing and commercializing tissue repair products for three-dimensional (3D) bio-printing of tissues and organs, dermal fillers for aesthetics, orthobiologics, and advanced wound care markets in the United States, Canada, and Europe. The company's products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. Its products include VergenixSTR, a soft tissue repair matrix intended for treatment of tendinopathy; VergenixFG, a wound-filling flowable gel for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; and BioInks for 3D printing of tissues and organs. CollPlant Holdings Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.94 out of 5 stars


Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CLGN
CUSIPN/A
CIKN/A
Phone972-73-232-5600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.32 million
Book Value$1.07 per share

Profitability

Net Income$-11,160,000.00
Net Margins-418.48%

Miscellaneous

Employees40
Market Cap$37.16 million
Next Earnings Date6/4/2020 (Estimated)
OptionableNot Optionable

Receive CLGN News and Ratings via Email

Sign-up to receive the latest news and ratings for CLGN and its competitors with MarketBeat's FREE daily newsletter.


COLLPLANT HOLDI/S (NASDAQ:CLGN) Frequently Asked Questions

How has COLLPLANT HOLDI/S's stock been impacted by COVID-19 (Coronavirus)?

COLLPLANT HOLDI/S's stock was trading at $10.20 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CLGN stock has decreased by 4.5% and is now trading at $9.74. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of COLLPLANT HOLDI/S?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for COLLPLANT HOLDI/S in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for COLLPLANT HOLDI/S.

When is COLLPLANT HOLDI/S's next earnings date?

COLLPLANT HOLDI/S is scheduled to release its next quarterly earnings announcement on Thursday, June 4th 2020. View our earnings forecast for COLLPLANT HOLDI/S.

What price target have analysts set for CLGN?

1 analysts have issued 1 year price targets for COLLPLANT HOLDI/S's shares. Their forecasts range from $11.00 to $11.00. On average, they expect COLLPLANT HOLDI/S's stock price to reach $11.00 in the next year. This suggests a possible upside of 12.9% from the stock's current price. View analysts' price targets for COLLPLANT HOLDI/S.

Has COLLPLANT HOLDI/S been receiving favorable news coverage?

News coverage about CLGN stock has been trending very negative recently, InfoTrie reports. The research firm scores the sentiment of media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. COLLPLANT HOLDI/S earned a media sentiment score of -3.3 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutCOLLPLANT HOLDI/S.

Who are some of COLLPLANT HOLDI/S's key competitors?

What other stocks do shareholders of COLLPLANT HOLDI/S own?

Who are COLLPLANT HOLDI/S's key executives?

COLLPLANT HOLDI/S's management team includes the following people:
  • Prof. Oded Shoseyov, Founder & Chief Scientist Officer (Age 63)
  • Mr. Eran Rotem, Deputy CEO & CFO (Age 51)
  • Dr. Philippe David Bensimon, VP of Regulation Affairs & Quality Assurance (Age 54)
  • Dr. Nadav Orr, VP of R&D (Age 62)
  • Mr. Yehiel Tal, Chief Exec. Officer (Age 67)

When did COLLPLANT HOLDI/S IPO?

(CLGN) raised $22 million in an IPO on Friday, December 9th 2016. The company issued 3,500,000 shares at a price of $6.23 per share. Ladenburg Thalmann acted as the underwriter for the IPO and Roth Capital Partners was co-manager.

What is COLLPLANT HOLDI/S's stock symbol?

COLLPLANT HOLDI/S trades on the NASDAQ under the ticker symbol "CLGN."

How do I buy shares of COLLPLANT HOLDI/S?

Shares of CLGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is COLLPLANT HOLDI/S's stock price today?

One share of CLGN stock can currently be purchased for approximately $9.74.

How big of a company is COLLPLANT HOLDI/S?

COLLPLANT HOLDI/S has a market capitalization of $37.16 million and generates $2.32 million in revenue each year. The company earns $-11,160,000.00 in net income (profit) each year or ($1.29) on an earnings per share basis. COLLPLANT HOLDI/S employs 40 workers across the globe. View additional information about COLLPLANT HOLDI/S.

What is COLLPLANT HOLDI/S's official website?

The official website for COLLPLANT HOLDI/S is http://www.collplant.com/.

How can I contact COLLPLANT HOLDI/S?

COLLPLANT HOLDI/S's mailing address is 4 OPPENHEIMER ST. P.O.B 4132, REHOVOT L3, 7670104. The company can be reached via phone at 972-73-232-5600 or via email at [email protected]

This page was last updated on 4/8/2020 by MarketBeat.com Staff

Featured Article: Bid-Ask Spread

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel